Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Novel antibody helps block COVID transmission in cells, finds study
The antibody, FuG1, targets the enzyme furin, which the virus uses for its efficient chain of infections in human cells
Glenmark inks agreement with AstraZeneca to commercialise Pulmicort Respules in Colombia
As per this agreement, AstraZeneca remains the holder of the registration for Pulmicort Respules, and will manufacture the drug.…
ProBioGen signs commercial licence agreement with AstraZeneca for using GlymaxX technology
Following evaluation of the technology under a research license, AstraZeneca will now continue to use GlymaxX and will integrate…
US FDA authorises Eli Lilly’s COVID-19 antibody drug
The FDA authorised bebtelovimab for emergency use in patients with mild-to-moderate COVID-19 who are at high risk of progression…
China approves use of Pfizer’s COVID drug Paxlovid
It is not immediately clear if China is already in talks with Pfizer to procure the pill
Zydus gets 180 days’ shared exclusivity for Roflumilast tablets
Zydus’ Roflumilast tablets are indicated as a treatment to reduce the risk of Chronic Obstructive Pulmonary Disease (COPD)…
WHO grants prequalification of Roche’s Actemra/RoActemra for patients with severe COVID
Since the beginning of the pandemic, more than one million patients with severe COVID-19 have been treated with Actemra/RoActemra,…
LANXESS appoints Neelanjan Banerjee as Global Head of its Lubricant Additives Business
Banerjee is taking over from Martin Saewe who moves on to become the Head of Group Initiative E-Mobility and Circular Economy
Novartis India extends access to its medicines in India with Dr Reddy’s Laboratories
This brings together the manufacturing and development synergies of Novartis with the sales and distribution strengths of Dr…
EdiGene and Neukio enter collaboration to develop next-generation immune cell therapies
The collaboration will leverage EdiGene’s expertise in high-throughput genome editing screening and Neukio’s strength in the…